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SIFT-MS
• Selected Ion Flow Tube Mass Spectrometry
• Chemical ionisation of positively charged precursor ions that react 
with the VOCs in air/breath sample
1. Precursor ions generated 
2. Quadrupole mass filter 
selects required precursor
3. Precursor ion injected into 
inert carrier gas 
4. Reaction of VOCs and 
precursor
5. Product ions filtered 
according to mass
6. Product ions counted in 
channeltron particle 
multiplier/detector
Introduction
• SIFT-MS offers real-time quantification of trace gases
• The SIFT-MS system can potentially offer unique clinical capabilities 
–Early and rapid detection of disease, infectious bacteria and/or patient condition 
would have significant clinical impact
• Requires: a classifier to differentiate between control and test groups.
• Goal: classification and/or identification of the masses and VOCs that 
contribute most strongly  towards a successful classification
• Outcome: may allow new or improved biomarkers for a particular disease 
state or patient condition to be discovered
Classification
• Develop database and classify unknown sample into a 
database group
• Identify masses that contribute towards a successful 
classification and thus act as good biomarkers
• Use paired data to determine differences over time
• Overall there are two approaches:
– Classification + Biomarkers = a “pure” classification problem 
assuming independent patients and data
– Biomarker ID only = uses paired or grouped patient data to ID 
changes over state or time
Kernel Density Estimate
• Mixed distribution made up of a kernel density and a Dirac delta 
function is used to develop a density profile at each mass
Clearly different
One exception?Data
Kernel Estimate
Classifying unknown sample
• Probability of sample being in Group j given x0
• If ratio is greater than q, sample is classified in Group j
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Log-odds Ratio
• Log-odds ratio obtained for each mass
• Log-odds ratio ‘summed’ over all masses
• Ratio greater than ln[q/(1-q)] indicates the sample is in the 
numerator group (Group j)
• [If q = 0.5 and probability of Group k classification more likely at most masses, then 
the term:                          is negative]
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Prediction Error Estimation
• Alleviate bias using 0.632 estimator
• is the biased error using all data 
as training set
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• is the number of 
bootstrap samples that do not 
contain sample i
• is the classifier trained on 
bootstrap sample b
• equals 1 if 
classified incorrectly
• yi is the group xi belongs to
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• Stratified bootstrap method
– Choose with replacement from original sample
– Bootstrap sample created of same size as the original sample 
– Repeated B times (~1000)
Reliability
• Create density profiles of the log-odds ratios obtained
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ROC Curve
• The null hypothesis is that the unknown sample is in Group j. 
• Non-specificity = the probability of incorrectly rejecting the null 
hypothesis (classifying the sample as Group k when in fact it is 
Group j)
• Sensitivity = the probability of correctly rejecting the null hypothesis 
(classifying the sample as Group k when in fact it is Group k). 
Biomarkers – A simple method
• Biomarker Query –which masses contain minimal overlap 
(maximum separation) between log-odds density profiles?
Tedlar Bag “Idiot” Validation
• 25 nitrogen samples collected in a tedlar bag
• 25 nitrogen samples vented to sterile glass bottles 
• Probability density profiles use normalised concentration values
~Perfect – as expected
Dialysis Study Proof of Concept
• 7 repeat mass scans were taken of 1 dialysis patient 
• Mass scans taken at 1 and 4 hours = 14 total points (7 each group)
ROC Curve
Reliability Curve
Area ~0.89
Mass 36
Paired Data Approach
• Previous method: focus on differentiating between 2 distinct groups
• Goal: discover which masses, m, change the most between 2 
chosen time points, j and k, and thus act as good biomarkers for kidney function.
• Why not examine variations in patients before and after treatment?
– Paired data where data point in the pre-dialysis group (Group k) is linked to a specific data point in the post-dialysis group (Group j). 
• What trade-off can we find between adequate sample sizes and 
patient specific responses?
– Patients too variable to lump together (different temporal profile, starting and equilibrium concentration)
– Each patients dataset is too small to be considered independently
• These issues can be alleviated with the choice of an appropriatenormalisation method.
Normalisation
• Dialysis efficiency is usually determined by URR
• Consider a relative change in VOC concentration.  
• Normalise to half of the average of the two concentrations
• Data is bounded between [0 1] 
– > 0.5 = decrease in concentration over course of treatment
– <0.5 = increase in concentration. 
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Cj = concentration matrix of 
post-dialysis group
Ck = concentration matrix of 
pre-dialysis group
Biomarkers
• Select only masses with >0.5 non-zeros in either group
• Classify using selected biomarkers for sensitivity/specificity of that marker
• Biomarkers are displayed visually on an image plot using the 
difference between the pre- and post-dialysis groups. 
• Relative change, ∆rel
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Biomarkers
• Density profiles are created from the means of successful bootstrap samples using ∆rel and are combined into an image plot.  
• The distribution of the mean is the same as the distribution of the 
raw data 
– Create image plot off means for easier marker ID
• Select best biomarkers: highest mean to standard deviation ratio.  
– Masses with narrow distribution centered far from increase/decrease interface
– Crossing increase/decrease interface: bad biomarker
Dialysis proof-of-concept
• Raw data: sample size 39 before/after pairs
• Log-odds for minimum overlap
• Relative change for biomarker ID
ROC area ~ 0.995
Biomarker Image plot
• Best biomarker: largest consistent relative change in concentration
• Masses centered far from the decrease/increase interface with the 
narrowest distributions
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Summary
• Two classification methods developed and validated:
– Pure classification = assumes patients are independent and 
requires many patients and repeats
• Tedlar bag validation
• Dialysis proof-of-concept, but small sample size
– Paired classification = allows patients to be paired for classification 
rather than used independently, which effectively increases available 
data
• Dialysis study presented gave better results this way
• Methods interact with study design
– Number of patients and repeats per patient (i.e. quality and density 
of data you can get) will affect choice of method
– Emphasises integrated study and classifier design
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Questions or Comments?

SIFT-MS
0
50000
100000
150000
200000
250000
300000
350000
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150
• SIM scans and Mass Scans
• Scans taken every 0.2 mass unit
• Noise
• Reduce to concentration matrix for 
whole mass units
Mass (amu)
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Validation Study “Biomarkers”
1Water cluster of N2H more prevalent when N2passes through water.
47N2H+.H2O
6Due to the solubility of C6H6O.H+ in water, by venting the nitrogen through the water bottle, 
the concentration at mass 95 decreased 
dramatically.
95C6H6O.H+ (product of phenol)
7Due to the solubility of C4H9NO.H+ in water, by venting the nitrogen through the water bottle, 
the concentration at mass 88 decreased 
dramatically, (and increases at mass 106 – its 
water cluster).
88C4H9NO.H+ (product of N,N-dimethyl acetamide
2The wet nitrogen group showed much higher 
concentrations at mass 57, corresponding to the 
water clusters of H3O+, (and lower concentrations at mass 21, corresponding to the 
mass of the H3O+ isotope (D3O+) with no water cluster).
57Isotope of H3O+ and its water clusters
3, 4, 5 The wet nitrogen group showed much higher 
concentrations at masses 55 (and 73), 
corresponding to the water clusters of H3O+.
19, 55, 73H3O+ and its water clusters
RankExplanationMassProduct ions
